972TiP Phase II study of intratumoral MK-1454 plus pembrolizumab compared with pembrolizumab monotherapy as first-line treatment for metastatic or unresectable, recurrent head and neck squamous cell carcinoma
K.J. Harrington
◽
W.N. William
◽
A. Khilnani
◽
A.P. Algazi
2012 ◽
Vol 23
(4)
◽
pp. 1016-1022
◽
R. Hitt
◽
A. Irigoyen
◽
H. Cortes-Funes
◽
J.J. Grau
◽
J.A. García-Sáenz
◽
...
2016 ◽
Vol 122
(15)
◽
pp. 2350-2355
◽
Jared M. Weiss
◽
Stephen Bagley
◽
Wei-Ting Hwang
◽
Joshua Bauml
◽
Juneko Grilley Olson
◽
...
2021 ◽
Vol 32
◽
pp. S1432
D.A. Colevas
◽
K. Misiukiewicz
◽
A.T. Pearson
◽
J. Fayette
◽
J.R. Bauman
◽
...
2011 ◽
Vol 29
(15_suppl)
◽
pp. 5567-5567
◽
J. Guigay
◽
J. Fayette
◽
A. Dillies
◽
C. Sire
◽
J. N. Kerger
◽
...
G. Obara
◽
J. Sun
◽
D. Loo
◽
C. Bohac
2004 ◽
Vol 22
(14_suppl)
◽
pp. 5581-5581
A. Berrocal
◽
M. Pastor
◽
C. Caballero
◽
A. Segura
◽
S. Garcera
◽
...
Close
Export Citation Format
Close
Share Document
Close